Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2013

01-06-2013 | Clinical trial

Shared decision-making in metastatic breast cancer: discrepancy between the expected prolongation of life and treatment efficacy between patients and physicians, and influencing factors

Authors: Michael P. Lux, Christian M. Bayer, Christian R. Loehberg, Peter A. Fasching, Michael G. Schrauder, Mayada R. Bani, Lothar Häberle, Anne Engel, Katharina Heusinger, Thorsten Tänzer, Dragan Radosavac, Anton Scharl, Ingo Bauerfeind, Judith Gesslein, Hilde Schulte, Brigitte Overbeck-Schulte, Matthias W. Beckmann, Alexander Hein

Published in: Breast Cancer Research and Treatment | Issue 2/2013

Login to get access

Abstract

Treatment decisions in oncology are based on a balance between the efficacy of therapy and its side effects. Patients with metastases and patients with a limited prognosis are a particular challenge, since communication about the disease situation and the expected therapeutic benefit is difficult not only for patients, but also for physicians. The aim of this study was therefore to compare the benefits expected of therapy by patients and physicians. Questionnaires were sent to 9,000 breast cancer patients and to 6,938 physicians. The questionnaires described 10 cases of breast cancer in the metastatic setting. The patients and physicians were asked to state the treatment benefit they would require to decide for the therapy options chemotherapy, endocrine therapy, antibody therapy, radiotherapy, and bisphosphonates. Additionally, the participants provided data on patient and physician characteristics. Expected treatment benefits were compared between patients and physicians, and influencing factors that modified the expected benefit were identified. Patients expected much greater benefits from the therapies offered than the physicians. For all treatment modalities, about 50 % or more of patients expected more than a 12-month increase in overall survival from all therapies. Among the doctors, this proportion ranged from 7 to 30 %. Among patients, previous experience of side effects and having young children in the family were the strongest influencing factors. Among the doctors, age and level of education had a strong influence on the expected prognostic improvement to indicate a therapy option. As expectations of treatment differ greatly between patients and doctors, a structured approach to solving this conflict is required. There appear to be some indicators that might help address the problem, such as the physicians’ level of training and experience and the patients’ specific social circumstances.
Literature
2.
go back to reference Robert Koch-Institut (2010) Verbreitung von Krebserkrankungen in Deutschland. Entwicklung der Prävalenzen zwischen 1990 und 2010. Beiträge zur Gesundheitsberichterstattung des Bundes. Westkreuz-Druckerei, Berlin Robert Koch-Institut (2010) Verbreitung von Krebserkrankungen in Deutschland. Entwicklung der Prävalenzen zwischen 1990 und 2010. Beiträge zur Gesundheitsberichterstattung des Bundes. Westkreuz-Druckerei, Berlin
4.
go back to reference Kolberg HC, Luftner D, Lux MP, Maass N, Schutz F, Fasching PA, Fehm T, Janni W, Kummel S (2012) Breast cancer 2012-new aspects. Geburtshilfe Frauenheilkd 72(7):602–615. doi:10.1055/s-0032-1315131 CrossRef Kolberg HC, Luftner D, Lux MP, Maass N, Schutz F, Fasching PA, Fehm T, Janni W, Kummel S (2012) Breast cancer 2012-new aspects. Geburtshilfe Frauenheilkd 72(7):602–615. doi:10.​1055/​s-0032-1315131 CrossRef
5.
go back to reference Kummel S, Kolberg HC, Luftner D, Lux MP, Maass N, Schutz F, Fasching PA, Fehm T, Janni W (2011) Breast cancer 2011-new aspects. Geburtshilfe Frauenheilkd 71(11):939–953. doi:10.1055/s-0031-1280313 CrossRef Kummel S, Kolberg HC, Luftner D, Lux MP, Maass N, Schutz F, Fasching PA, Fehm T, Janni W (2011) Breast cancer 2011-new aspects. Geburtshilfe Frauenheilkd 71(11):939–953. doi:10.​1055/​s-0031-1280313 CrossRef
6.
go back to reference Albert US, Koller M, Wagner U, Schulz KD (2004) Survival chances and psychological aspects of quality of life in patients with localized early stage breast cancer. Inflamm Res 53(Suppl 2):S136–S141. doi:10.1007/s00011-004-0365-2 PubMed Albert US, Koller M, Wagner U, Schulz KD (2004) Survival chances and psychological aspects of quality of life in patients with localized early stage breast cancer. Inflamm Res 53(Suppl 2):S136–S141. doi:10.​1007/​s00011-004-0365-2 PubMed
7.
go back to reference Chouliara Z, Kearney N, Stott D, Molassiotis A, Miller M (2004) Perceptions of older people with cancer of information, decision making and treatment: a systematic review of selected literature. Ann Oncol 15(11):1596–1602. doi:10.1093/annonc/mdh423 PubMedCrossRef Chouliara Z, Kearney N, Stott D, Molassiotis A, Miller M (2004) Perceptions of older people with cancer of information, decision making and treatment: a systematic review of selected literature. Ann Oncol 15(11):1596–1602. doi:10.​1093/​annonc/​mdh423 PubMedCrossRef
9.
go back to reference Loehberg CR, Almstedt K, Jud SM, Haeberle L, Fasching PA, Hack CC, Lux MP, Thiel FC, Schrauder MG, Brunner M, Bayer CM, Hein A, Heusinger K, Heimrich J, Bani MR, Renner SP, Hartmann A, Beckmann MW, Wachter DL (2013) Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis. Breast Cancer Res Treat 138(3):899–908. doi:10.1007/s10549-013-2460-y PubMedCrossRef Loehberg CR, Almstedt K, Jud SM, Haeberle L, Fasching PA, Hack CC, Lux MP, Thiel FC, Schrauder MG, Brunner M, Bayer CM, Hein A, Heusinger K, Heimrich J, Bani MR, Renner SP, Hartmann A, Beckmann MW, Wachter DL (2013) Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis. Breast Cancer Res Treat 138(3):899–908. doi:10.​1007/​s10549-013-2460-y PubMedCrossRef
10.
go back to reference Lobb EA, Butow PN, Meiser B, Barratt A, Gaff C, Young MA, Kirk J, Suthers GK, Tucker K (2002) Tailoring communication in consultations with women from high risk breast cancer families. Br J Cancer 87(5):502–508. doi:10.1038/sj.bjc.6600484 PubMedCrossRef Lobb EA, Butow PN, Meiser B, Barratt A, Gaff C, Young MA, Kirk J, Suthers GK, Tucker K (2002) Tailoring communication in consultations with women from high risk breast cancer families. Br J Cancer 87(5):502–508. doi:10.​1038/​sj.​bjc.​6600484 PubMedCrossRef
11.
go back to reference Siminoff LA, Fetting JH, Abeloff MD (1989) Doctor-patient communication about breast-cancer adjuvant therapy. J Clin Oncol 7(9):1192–1200PubMed Siminoff LA, Fetting JH, Abeloff MD (1989) Doctor-patient communication about breast-cancer adjuvant therapy. J Clin Oncol 7(9):1192–1200PubMed
12.
go back to reference Gattellari M, Voigt KJ, Butow PN, Tattersall MH (2002) When the treatment goal is not cure: are cancer patients equipped to make informed decisions? J Clin Oncol 20(2):503–513PubMedCrossRef Gattellari M, Voigt KJ, Butow PN, Tattersall MH (2002) When the treatment goal is not cure: are cancer patients equipped to make informed decisions? J Clin Oncol 20(2):503–513PubMedCrossRef
13.
go back to reference Koedoot CG, Oort FJ, de Haan RJ, Bakker PJ, de Graeff A, de Haes JC (2004) The content and amount of information given by medical oncologists when telling patients with advanced cancer what their treatment options are palliative chemotherapy and watchful-waiting. Eur J Cancer 40(2):225–235PubMedCrossRef Koedoot CG, Oort FJ, de Haan RJ, Bakker PJ, de Graeff A, de Haes JC (2004) The content and amount of information given by medical oncologists when telling patients with advanced cancer what their treatment options are palliative chemotherapy and watchful-waiting. Eur J Cancer 40(2):225–235PubMedCrossRef
14.
go back to reference Oostendorp LJ, Ottevanger PB, van der Graaf WT, Stalmeier PF (2011) Assessing the information desire of patients with advanced cancer by providing information with a decision aid, which is evaluated in a randomized trial: a study protocol. BMC Med Inform Decis Mak 11:9. doi:10.1186/1472-6947-11-9 PubMedCrossRef Oostendorp LJ, Ottevanger PB, van der Graaf WT, Stalmeier PF (2011) Assessing the information desire of patients with advanced cancer by providing information with a decision aid, which is evaluated in a randomized trial: a study protocol. BMC Med Inform Decis Mak 11:9. doi:10.​1186/​1472-6947-11-9 PubMedCrossRef
15.
go back to reference Tattersall MH, Butow PN, Clayton JM (2002) Insights from cancer patient communication research. Hematol Oncol Clin North Am 16(3):731–743PubMedCrossRef Tattersall MH, Butow PN, Clayton JM (2002) Insights from cancer patient communication research. Hematol Oncol Clin North Am 16(3):731–743PubMedCrossRef
16.
go back to reference Bruera E, Sweeney C, Calder K, Palmer L, Benisch-Tolley S (2001) Patient preferences versus physician perceptions of treatment decisions in cancer care. J Clin Oncol 19(11):2883–2885PubMed Bruera E, Sweeney C, Calder K, Palmer L, Benisch-Tolley S (2001) Patient preferences versus physician perceptions of treatment decisions in cancer care. J Clin Oncol 19(11):2883–2885PubMed
17.
go back to reference Thiel FC, Schrauder MG, Fasching PA, Lohberg CR, Bani MR, Haberle L, Tanzer T, Radosavac D, Scharl A, Bauerfeind I, Gesslein J, Schulte H, Overbeck-Schulte B, Beckmann MW, Lux MP (2012) Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physicians. Breast Cancer Res Treat 135(3):811–820. doi:10.1007/s10549-012-2218-y PubMedCrossRef Thiel FC, Schrauder MG, Fasching PA, Lohberg CR, Bani MR, Haberle L, Tanzer T, Radosavac D, Scharl A, Bauerfeind I, Gesslein J, Schulte H, Overbeck-Schulte B, Beckmann MW, Lux MP (2012) Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physicians. Breast Cancer Res Treat 135(3):811–820. doi:10.​1007/​s10549-012-2218-y PubMedCrossRef
18.
go back to reference Angus VC, Entwistle VA, Emslie MJ, Walker KA, Andrew JE (2003) The requirement for prior consent to participate on survey response rates: a population-based survey in Grampian. BMC Health Serv Res 3(1):21. doi:10.1186/1472-6963-3-21 PubMedCrossRef Angus VC, Entwistle VA, Emslie MJ, Walker KA, Andrew JE (2003) The requirement for prior consent to participate on survey response rates: a population-based survey in Grampian. BMC Health Serv Res 3(1):21. doi:10.​1186/​1472-6963-3-21 PubMedCrossRef
19.
go back to reference Matsuda T, Marche H, Grosclaude P, Clement S (2004) Participation behavior of bladder cancer survivors in a medical follow-up survey on quality of life in France. Eur J Epidemiol 19(4):313–321PubMedCrossRef Matsuda T, Marche H, Grosclaude P, Clement S (2004) Participation behavior of bladder cancer survivors in a medical follow-up survey on quality of life in France. Eur J Epidemiol 19(4):313–321PubMedCrossRef
20.
go back to reference Renfroe EG, Heywood G, Foreman L, Schron E, Powell J, Baessler C, Warwick D, Morris M, Hallstrom A (2002) The end-of-study patient survey: methods influencing response rate in the AVID Trial. Control Clin Trials 23(5):521–533 S0197245602002258 [pii]PubMedCrossRef Renfroe EG, Heywood G, Foreman L, Schron E, Powell J, Baessler C, Warwick D, Morris M, Hallstrom A (2002) The end-of-study patient survey: methods influencing response rate in the AVID Trial. Control Clin Trials 23(5):521–533 S0197245602002258 [pii]PubMedCrossRef
21.
go back to reference Degner LF, Kristjanson LJ, Bowman D, Sloan JA, Carriere KC, O’Neil J, Bilodeau B, Watson P, Mueller B (1997) Information needs and decisional preferences in women with breast cancer. JAMA 277(18):1485–1492PubMedCrossRef Degner LF, Kristjanson LJ, Bowman D, Sloan JA, Carriere KC, O’Neil J, Bilodeau B, Watson P, Mueller B (1997) Information needs and decisional preferences in women with breast cancer. JAMA 277(18):1485–1492PubMedCrossRef
22.
go back to reference Lampic C, Wennberg A, Schill JE, Glimelius B, Brodin O, Sjoden PO (1994) Coping, psychosocial well-being and anxiety in cancer patients at follow-up visits. Acta Oncol 33(8):887–894PubMedCrossRef Lampic C, Wennberg A, Schill JE, Glimelius B, Brodin O, Sjoden PO (1994) Coping, psychosocial well-being and anxiety in cancer patients at follow-up visits. Acta Oncol 33(8):887–894PubMedCrossRef
24.
go back to reference Hagerty RG, Butow PN, Ellis PA, Lobb EA, Pendlebury S, Leighl N, Goldstein D, Lo SK, Tattersall MH (2004) Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol 22(9):1721–1730. doi:10.1200/JCO.2004.04.095 PubMedCrossRef Hagerty RG, Butow PN, Ellis PA, Lobb EA, Pendlebury S, Leighl N, Goldstein D, Lo SK, Tattersall MH (2004) Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol 22(9):1721–1730. doi:10.​1200/​JCO.​2004.​04.​095 PubMedCrossRef
25.
go back to reference Elit LM, Levine MN, Gafni A, Whelan TJ, Doig G, Streiner DL, Rosen B (1996) Patients’ preferences for therapy in advanced epithelial ovarian cancer: development, testing, and application of a bedside decision instrument. Gynecol Oncol 62(3):329–335. doi:10.1006/gyno.1996.0244 PubMedCrossRef Elit LM, Levine MN, Gafni A, Whelan TJ, Doig G, Streiner DL, Rosen B (1996) Patients’ preferences for therapy in advanced epithelial ovarian cancer: development, testing, and application of a bedside decision instrument. Gynecol Oncol 62(3):329–335. doi:10.​1006/​gyno.​1996.​0244 PubMedCrossRef
26.
go back to reference Brake H, Sassmann H, Noeres D, Neises M, Geyer S (2007) Ways to obtain a breast cancer diagnosis, consistency of information, patient satisfaction, and the presence of relatives. Support Care Cancer 15(7):841–847. doi:10.1007/s00520-006-0195-6 PubMedCrossRef Brake H, Sassmann H, Noeres D, Neises M, Geyer S (2007) Ways to obtain a breast cancer diagnosis, consistency of information, patient satisfaction, and the presence of relatives. Support Care Cancer 15(7):841–847. doi:10.​1007/​s00520-006-0195-6 PubMedCrossRef
28.
go back to reference Grunfeld EA, Maher EJ, Browne S, Ward P, Young T, Vivat B, Walker G, Wilson C, Potts HW, Westcombe AM, Richards MA, Ramirez AJ (2006) Advanced breast cancer patients’ perceptions of decision making for palliative chemotherapy. J Clin Oncol 24(7):1090–1098. doi:10.1200/JCO.2005.01.9208 PubMedCrossRef Grunfeld EA, Maher EJ, Browne S, Ward P, Young T, Vivat B, Walker G, Wilson C, Potts HW, Westcombe AM, Richards MA, Ramirez AJ (2006) Advanced breast cancer patients’ perceptions of decision making for palliative chemotherapy. J Clin Oncol 24(7):1090–1098. doi:10.​1200/​JCO.​2005.​01.​9208 PubMedCrossRef
29.
go back to reference Gustafson DH, Taylor JO, Thompson S, Chesney P (1993) Assessing the needs of breast cancer patients and their families. Qual Manag Health Care 2(1):6–17PubMed Gustafson DH, Taylor JO, Thompson S, Chesney P (1993) Assessing the needs of breast cancer patients and their families. Qual Manag Health Care 2(1):6–17PubMed
30.
go back to reference Liang W, Burnett CB, Rowland JH, Meropol NJ, Eggert L, Hwang YT, Silliman RA, Weeks JC, Mandelblatt JS (2002) Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction. J Clin Oncol 20(4):1008–1016PubMedCrossRef Liang W, Burnett CB, Rowland JH, Meropol NJ, Eggert L, Hwang YT, Silliman RA, Weeks JC, Mandelblatt JS (2002) Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction. J Clin Oncol 20(4):1008–1016PubMedCrossRef
31.
go back to reference Sigal JJ, Perry JC, Robbins JM, Gagne MA, Nassif E (2003) Maternal preoccupation and parenting as predictors of emotional and behavioral problems in children of women with breast cancer. J Clin Oncol 21(6):1155–1160PubMedCrossRef Sigal JJ, Perry JC, Robbins JM, Gagne MA, Nassif E (2003) Maternal preoccupation and parenting as predictors of emotional and behavioral problems in children of women with breast cancer. J Clin Oncol 21(6):1155–1160PubMedCrossRef
32.
go back to reference Billhult A, Segesten K (2003) Strength of motherhood: nonrecurrent breast cancer as experienced by mothers with dependent children. Scand J Caring Sci 17(2):122–128PubMedCrossRef Billhult A, Segesten K (2003) Strength of motherhood: nonrecurrent breast cancer as experienced by mothers with dependent children. Scand J Caring Sci 17(2):122–128PubMedCrossRef
34.
35.
go back to reference Yoshida S, Otani H, Hirai K, Ogata A, Mera A, Okada S, Oshima A (2010) A qualitative study of decision-making by breast cancer patients about telling their children about their illness. Support Care Cancer 18(4):439–447. doi:10.1007/s00520-009-0682-7 PubMedCrossRef Yoshida S, Otani H, Hirai K, Ogata A, Mera A, Okada S, Oshima A (2010) A qualitative study of decision-making by breast cancer patients about telling their children about their illness. Support Care Cancer 18(4):439–447. doi:10.​1007/​s00520-009-0682-7 PubMedCrossRef
38.
go back to reference Lamont EB, Christakis NA (2001) Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med 134(12):1096–1105 200106190-00009 [pii]PubMedCrossRef Lamont EB, Christakis NA (2001) Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med 134(12):1096–1105 200106190-00009 [pii]PubMedCrossRef
39.
Metadata
Title
Shared decision-making in metastatic breast cancer: discrepancy between the expected prolongation of life and treatment efficacy between patients and physicians, and influencing factors
Authors
Michael P. Lux
Christian M. Bayer
Christian R. Loehberg
Peter A. Fasching
Michael G. Schrauder
Mayada R. Bani
Lothar Häberle
Anne Engel
Katharina Heusinger
Thorsten Tänzer
Dragan Radosavac
Anton Scharl
Ingo Bauerfeind
Judith Gesslein
Hilde Schulte
Brigitte Overbeck-Schulte
Matthias W. Beckmann
Alexander Hein
Publication date
01-06-2013
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2013
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2557-3

Other articles of this Issue 2/2013

Breast Cancer Research and Treatment 2/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine